EP Patent

EP3047846A1 — Dosage forms containing fluticasone propionate for the treatment of inflammatory conditions of the esophagus

Assigned to EMS SA Brasil · Expires 2016-07-27 · 10y expired

What this patent protects

The present invention describes novel and improved dosage forms containing fluticasone propionate for the treatment of conditions associated with inflammation of the esophagus.

USPTO Abstract

The present invention describes novel and improved dosage forms containing fluticasone propionate for the treatment of conditions associated with inflammation of the esophagus.

Drugs covered by this patent

Patent Metadata

Patent number
EP3047846A1
Jurisdiction
EP
Classification
—
Expires
2016-07-27
Drug substance claim
No
Drug product claim
No
Assignee
EMS SA Brasil
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.